A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTIs) in children globally. Predisposing conditions for the development of serious RSV disease include preterm infants and those with cardiopulmonary illness, including congenital heart disease (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Turti, Tatyana V, Baibarina, Elena N, Degtiareva, Elena A, Keshishyan, Elena S, Lobzin, Yurii V, Namazova-Вaranova, Leyla S, Prodeus, Andrey P, Gudkov, Konstantin M, Kruglova, Anna I, Schulz, Gregory A, Notario, Gerard F
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532356/
https://ncbi.nlm.nih.gov/pubmed/22943074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-5-484
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares